The body contouring market, including noninvasive and minimally invasive fat reduction procedures, is set to rise from $671.8 million in 2015 to over $1.1 billion by 2022, representing a compound annual growth rate of 7.9%, according to research and consulting firm GlobalData.
The company’s latest report states that this growth—which will occur across the 15 major markets of the U.S., France, Germany, Italy, Spain, the U.K., Japan, China, India, Brazil, Australia, Canada, Mexico, Russia and South Korea—will be driven by rising obesity rates, increasing numbers of men seeking cosmetic procedures, and advancement in the availability and quality of nonsurgical procedures.
GolbalData reports that the number of men who underwent noninvasive body contouring treatments in the U.S. increased from 14,598 in 2012 to 26,902 by 2015, an annual increase of 22.6%. In 2015, 16.7% of nonsurgical fat reduction procedures were performed on men in the U.S., with similar trends being seen in other major market countries as well.
“The global obesity epidemic is significantly increasing the number of people seeking body contouring procedures. Despite the fact that it is recommended to only use the procedures as a method to remove small pockets of fat, people continue to look for easier alternatives to diet and exercise for reducing their body fat content and are increasingly turning to body contouring,” said Brigitte Babin, GlobalData’s analyst covering medical devices. “While some patients choose to try noninvasive methods first, the noninvasive or nonsurgical trend is primarily driven by patients who would otherwise not undergo any form of fat reduction or body contouring. For patients with an aversion for unnecessary surgery, fear of surgical complications or financial restrictions, nonsurgical options overcome all of these factors deterring patients from seeking body contouring treatments.”